I have enclosed some information for your review detailing the services LabCorp offers and our history as a company.

Transcription

1 J(.,< ~'A : _ -~ = -==== - ===-== ~ Labor~ry Corpora;;; ofa;,e:a =- Laboratory Corporation of America 4500 Conaem Drive Louisville, Kentucky Telephone: February 5, 2009 Ghida Neukirch Deputy Village Manager Fifty Raupp Blvd. Buffalo Grove, IL Dear Ms. Neukirch: I am writing to formally request an informal poll of the city council to see if Laboratory Corporation of America Holdings ("LabCorp") could obtain a special use permit for a space LabCorp wishes to lease at 206 McHenry Rd., Buffalo Grove, IL. LabCorp wishes to place a Patient Service Center/Draw Station at this location where we shall provide routine adult and pediatric specimen collections for diagnostic testing and screening in a professional environment. This location will be utilized solely as a collection center and no testing shall be performed. LabCorp will initially have one employee stationed at this location and within one year we hope to increase that number to a minimum of two. Currently we are estimating this location will initially service thirty five to forty patients per day and we expect that number to expand to approximately sixty to seventy per day. I have enclosed some information for your review detailing the services LabCorp offers and our history as a company. If you should have any questions or need additional information, please feel free to contact me at ext or via atblairr@labcorp.com.llook forward to hearing from you soon. Sincerely, Rhonda S. Blair Divisional Leasing and Contracting Manager Regional Compliance Officer

2 About LabCorp LabCorp provides leading-edge medicallablora1to tests services through a national network of primary clinical laboratories and specialized Centers of Excellence. Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than one million tests on approximately 400,000 samples each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and over 28,000 employees worldwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH. HEADQUARTERS: 358 South Main Street Burlington, North Carolina (336) TICKER SYMBOL: LH ESTABLISHED: 1971 NUMBEROF EMPLOYEES: Approximately 28,000 worldwide ANNUAL REVENUE: $4.5 Billion (2008) CHIEF EXECUTIVEOFFICER David P. King PATIENT SERVICE CENTERS: LabCorp maintains a network of more than 1,600

3 Patient Service Centers (PSC) nationally. These sites are strategically located throughout United States the CENTERSOF EXCELLENCE: LabCorp operates a nationwide network of 36 primary testing locations and combines its expertise in innovative clinical testing technology with the following specialized Centers of Excellence: The ViroMed National DIANON US Esoterix, LABS Center Genetics Systems, Inc. for Molecular Esoteric Institute Inc. Testing Biology (NGI) and (CET) Pathology (CMBP) OUR BUSINESS: As a pioneer in genomic testing and the commercialization of new diagnostic technologies, LabCorp is one of the world's largest clinical laboratories. LabCorp is also listed on the S&P 500. We offer a broad range of routine and esoteric/genomic assays, and test more than 370,000 specimens daily for over 220,000 clients nationwide. LabCorp's reputation and proven record in the area of advanced genomic testing continues to attract the leading minds and technological pioneers in the field.

4 Company History About LabCorp Hoffmann-La Roche acquireskings CountyResearch Laboratories Hoffman-LaRocheand Biomedical Referen celabs consolidatemformroche, Biomedical Laooratories Ine. D!:!~~!rp RocheBiomedical andnhl mergemformlaooramry Corporation ofamerica OlAllaII IEsoterix, Systems Int Monogram Biosciences &2 Or.James liahmai HealthlA borato- IIIHl acquires Powell founds Biomedical I ReylonHealthCareGroup riesi; launebedasapartof IAllied(Iinical Health(19S14) Laboratories Geneti:sllabora- NatDnaI IVimilled IJynacare, Int Instituteimries IlithOlink jtandem I laboratories ILABS US Corp Many people think of LabCorp simply as the merger of Roche Biomedical Laboratories and National Health Laboratories in However, our roots extend back to 1905 when Hoffmann-La Roche began operations in the United States. Hoffmann-La Roche officially entered the lab business when it acquired the Kings County Research Laboratory in About the same time as Hoffmann-La Roche was purchasing Kings County Research Laboratory, Thomas Edward Powell III, and his twin brothers, Dr. James B. Powell and John Powell, were forming Biomedical Laboratories (later known as Biomedical Reference Laboratories) in a hospital basement in Burlington, NC. After a number of acquisitions, Hoffmann-La Roche acquired Biomedical Reference Laboratories in In 1983, Hoffmann-La Roche merged all of its laboratory companies into one company, which it called Roche Biomedical Laboratories (RBL). Prior to the formation of RBL, National Health Laboratories (NHL) was formed in NHL, owned by the Revlon Health Care Group, grew to $761 million in revenue by In 1994, NHL further broadened its laboratory testing capabilities by acquiring the sixth largest clinical lab in the US, Allied Clinical Health. By the mid 1990s NHL and RBL were two of the largest clinical, drug-screening, and paternity laboratories in the US. In 1995, National Health Laboratories and Roche Biomedical Laboratories merged to become one of the largest clinical lab provider in the world. Initially led by Dr. James Powell, the new company - Laboratory Corporation of America - was headquartered in Burlington, NC. Over the last 10 years, LabCorp has continued to expand our esoteric and specialty laboratory testing capabilities by acquiring scientific leaders in the genomics, anatomic pathology, and personalized medicine arenas. In July 2000, LabCorp acquired Los Angeles-based National Genetics Institute, allowing LabCorp to gain NGI's ultra-sensitive hepatitis C testing capability. In 2001, ViroMed, one of the leading laboratories in molecular microbial testing using real-time PCR platforms, became a part of LabCorp. LabCorp acquired Dynacare with locations in

5 Washington, Tennessee, Wisconsin, and Canada in June In 2005, LabCorp acquired Esoterix, Inc. and its leading specialty labs - Colorado Coagulation, Endocrine Sciences, and Cytometry Associates. In conjunction with our investments in expanding our esoteric testing capabilities, LabCorp continues to invest in building the most robust anatomic pathology capabilities in the world. LabCorp further strengthened its anatomic pathology capabilities by acquiring DIANON Systems in 2003 and US LABS in DIANON is distinguished for its capabilities in specific organ systems and clinical disciplines of uropathology, dermatopathology, and gastrointestinal pathology. US LABS' extensive menu of esoteric oncology testing and expertise across multiple methodologies further balanced LabCorp's anatomic pathology capabilities. In 2006, LabCorp acquired Litholink, a premier provider for assisting physicians and their patients with outcomes management. The impact of these outcomes management programs in preventing disease recurrence or disease progression is impressive. More recently, LabCorp has expanded its clinical trials, personalized medicine, and companion diagnostic capabilities by purchasing Tandem Laboratories in 2008 and Monogram Biosciences in Tandem Laboratories is a leading bioanalytical and immunoanalytical contract research organization (CRO) supporting pharmaceutical and biotechnology companies with their discovery, preclinical, and clinical drug development programs. Monogram Biosciences is a recognized leader in the discovery and commercialization of products to guide and improve the treatment of HIV, cancer, and other serious diseases. Today, LabCorp operates a sophisticated laboratory network and logistics infrastructure, with more than 28,000 employees worldwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. LabCorp accessions more than 400,000 samples per day and annually examines in excess of 10 million cytology and 2 million surgical pathology samples. We have continued to innovate internally and invest strategically in scientific excellence, and we continue to be passionate about patient care and quality.